SG11201510238TA - Renal progenitor cells - Google Patents
Renal progenitor cellsInfo
- Publication number
- SG11201510238TA SG11201510238TA SG11201510238TA SG11201510238TA SG11201510238TA SG 11201510238T A SG11201510238T A SG 11201510238TA SG 11201510238T A SG11201510238T A SG 11201510238TA SG 11201510238T A SG11201510238T A SG 11201510238TA SG 11201510238T A SG11201510238T A SG 11201510238TA
- Authority
- SG
- Singapore
- Prior art keywords
- progenitor cells
- renal progenitor
- renal
- cells
- progenitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0687—Renal stem cells; Renal progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Developmental Biology & Embryology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013902215A AU2013902215A0 (en) | 2013-06-14 | Renal progenitor cells | |
| AU2013904580A AU2013904580A0 (en) | 2013-11-27 | Renal progenitor cells | |
| PCT/AU2014/000608 WO2014197934A1 (en) | 2013-06-14 | 2014-06-13 | Renal progenitor cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201510238TA true SG11201510238TA (en) | 2016-01-28 |
Family
ID=52021491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510238TA SG11201510238TA (en) | 2013-06-14 | 2014-06-13 | Renal progenitor cells |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10900022B2 (en) |
| EP (1) | EP3011014A4 (en) |
| JP (2) | JP2016527878A (en) |
| KR (1) | KR102375753B1 (en) |
| CN (1) | CN105473706B (en) |
| AU (1) | AU2014280843B2 (en) |
| BR (1) | BR112015031094A2 (en) |
| CA (1) | CA2915097C (en) |
| HK (1) | HK1223976A1 (en) |
| NZ (1) | NZ715302A (en) |
| RU (1) | RU2016100232A (en) |
| SG (1) | SG11201510238TA (en) |
| WO (1) | WO2014197934A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9719068B2 (en) | 2010-05-06 | 2017-08-01 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into intestinal tissues through directed differentiation |
| NZ715302A (en) | 2013-06-14 | 2021-12-24 | Univ Queensland | Renal progenitor cells |
| MX2015017330A (en) * | 2013-07-29 | 2016-04-06 | Hoffmann La Roche | Method for differentiation of pluripotent stem cells into multi-competent renal precursors. |
| CA2949834A1 (en) | 2014-05-28 | 2015-12-03 | James Macormack Wells | Methods and systems for converting precursor cells into gastric tissues through directed differentiation |
| JP6804438B2 (en) | 2014-10-17 | 2020-12-23 | チルドレンズ ホスピタル メディカル センター | An in vivo model of the human small intestine using pluripotent stem cells, and methods for making and using it. |
| AU2014277667B2 (en) * | 2014-12-15 | 2022-07-14 | The University Of Queensland | Differentiation of pluripotent stem cells to form renal organoids |
| EP3344264B1 (en) * | 2015-09-03 | 2023-03-15 | The Brigham and Women's Hospital, Inc. | Three-dimensional differentiation of epiblast spheroids to kidney organoids models stage-specific epithelial physiology, morphogenesis, and disease |
| JP2018527007A (en) * | 2015-09-17 | 2018-09-20 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． | Methods for generating nephrons from human pluripotent stem cells |
| CA3016641A1 (en) | 2016-05-05 | 2017-11-09 | Children's Hospital Medical Center | Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same |
| DK3519558T3 (en) | 2016-09-28 | 2023-11-13 | Organovo Inc | USE OF MODIFIED KIDNEY TISSUE IN ASSAYS |
| CN110062764A (en) | 2016-12-05 | 2019-07-26 | 儿童医院医学中心 | Colon organoid and its preparation and application |
| WO2018213886A1 (en) | 2017-05-24 | 2018-11-29 | Murdoch Childrens Research Institute | Genetically induced nephron progenitors |
| CA3064830A1 (en) * | 2017-05-25 | 2018-11-29 | Kyoto University | Method for inducing differentiation of intermediate mesodermal cell to renal progenitor cell, and method for inducing differentiation of pluripotent stem cell to renal progenitor cell |
| US11834680B2 (en) | 2017-06-28 | 2023-12-05 | Rutgers, The State University Of New Jersey | Single kidney cell-derived organoids |
| SG11202003790PA (en) * | 2017-10-31 | 2020-05-28 | Murdoch Childrens Res Inst | Composition and method |
| CN110468095A (en) * | 2019-09-05 | 2019-11-19 | 安徽中盛溯源生物科技有限公司 | A kind of renal epithelial cell and its preparation method and application |
| EP4043553A4 (en) * | 2019-10-01 | 2023-11-22 | Kyoto University | Method for isolating ureteric bud tip cells |
| CN111961640B (en) * | 2020-04-27 | 2023-05-12 | 同济大学 | Construction method and culture system of three-dimensional differentiation model of urine-derived renal stem cells |
| CN111638342A (en) * | 2020-07-08 | 2020-09-08 | 上海市浦东新区公利医院(第二军医大学附属公利医院) | Application of SOX17 protein in preparation of renal clear cell carcinoma diagnosis or prognosis evaluation kit |
| WO2023028550A1 (en) * | 2021-08-26 | 2023-03-02 | Vanderbilt University | Accelerated protocol for the differentiation of podocytes from human pluripotent stem cells |
| WO2023033137A1 (en) | 2021-09-03 | 2023-03-09 | 大塚製薬株式会社 | Kidney organoid and method for producing same |
| WO2023060190A1 (en) | 2021-10-08 | 2023-04-13 | Vanderbilt University | Nephron progenitor exosomes |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517872B1 (en) | 1995-06-12 | 2003-02-11 | Yeda Research And Development Co., Ltd. | FGFR3 as a marker for mesenchymal skeletal progenitor cells |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6489344B1 (en) | 1998-06-19 | 2002-12-03 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
| US7439064B2 (en) | 2000-03-09 | 2008-10-21 | Wicell Research Institute, Inc. | Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium |
| US7326570B2 (en) | 2000-06-16 | 2008-02-05 | The Regents Of The University Of California | Induction of tubular morphogenesis using pleiotrophin |
| US6477783B1 (en) | 2000-09-19 | 2002-11-12 | The United States Of America As Represented By The Secretary Of Transportation | Gyratory compactor angle measurement device |
| JP2005510232A (en) * | 2001-11-26 | 2005-04-21 | アドバンスド セル テクノロジー、インク． | Production and use of reprogrammed human somatic cell nuclei and autologous and syngeneic human stem cells |
| CN1845987A (en) | 2003-08-29 | 2006-10-11 | 明尼苏达大学董事会 | Kidney derived stem cells and methods for their isolation, differentiation and use |
| WO2005075636A1 (en) * | 2004-02-09 | 2005-08-18 | The University Of Queensland | Molecular markers associated with metanephric development and renal progenitors |
| US8597947B2 (en) | 2004-12-29 | 2013-12-03 | Hadasit Medical Research Services & Development Limited | Undifferentiated stem cell culture systems |
| CA2645170A1 (en) | 2006-03-30 | 2007-10-11 | The University Court Of The University Of Edinburgh | Culture medium containing kinase inhibitors, and uses thereof |
| GB0615327D0 (en) | 2006-03-30 | 2006-09-13 | Univ Edinburgh | Culture medium containing kinase inhibitors and uses thereof |
| WO2008085879A2 (en) | 2007-01-03 | 2008-07-17 | California Stem Cell, Inc. | Stem cell growth media and methods of making and using same |
| US8263403B2 (en) | 2007-04-23 | 2012-09-11 | Stowers Institute For Medical Research | Methods and compositions for stem cell self-renewal |
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| DK2297307T3 (en) | 2008-06-04 | 2016-07-25 | Cellular Dynamics Int Inc | PROCEDURES FOR THE MANUFACTURE OF IPS CELLS USING NON-VIRAL METHODS |
| US8278105B2 (en) | 2008-09-09 | 2012-10-02 | University Of Southern California | Induction, propagation and isolation of liver progenitor cells |
| EP3312269A1 (en) | 2008-12-17 | 2018-04-25 | The Scripps Research Institute | Generation and maintenance of stem cells |
| WO2010108126A2 (en) | 2009-03-19 | 2010-09-23 | Fate Therapeutics, Inc. | Reprogramming compositions and methods of using the same |
| US10894944B2 (en) | 2009-04-10 | 2021-01-19 | Monash University | Cell culture media |
| AU2010285788B2 (en) | 2009-08-17 | 2014-04-24 | Organ Technologies, Inc. | Process for production of bioartificial organ |
| CN102242146B (en) | 2010-05-10 | 2015-11-25 | 高丽大学校产学协力团 | Composition and the method with its generation generate induced pluripotent stem cells |
| ES2672918T3 (en) | 2010-05-13 | 2018-06-18 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Isolated populations of adult renal cells and methods to isolate and use them |
| JP5896360B2 (en) | 2010-07-21 | 2016-04-13 | 国立大学法人京都大学 | Method for inducing differentiation from human pluripotent stem cells to intermediate mesoderm cells |
| WO2013056072A1 (en) | 2011-10-13 | 2013-04-18 | Wisconsin Alumni Research Foundation | Generation of cardiomyocytes from human pluripotent stem cells |
| WO2013094771A1 (en) | 2011-12-19 | 2013-06-27 | Kyoto University | Method for inducing differentiation of human pluripotent stem cells into intermediate mesoderm cells |
| KR20130119683A (en) | 2012-04-24 | 2013-11-01 | 사회복지법인 삼성생명공익재단 | Culture medium for stem cells and method for culturing stem cells using the same |
| KR101523040B1 (en) | 2012-06-26 | 2015-05-26 | 라정찬 | Method for Preparing High Concentration of Stem Cells |
| US8962322B2 (en) | 2012-12-03 | 2015-02-24 | City Of Hope | Enhancers of induced pluripotent stem cell reprogramming |
| US20150037883A1 (en) | 2013-03-03 | 2015-02-05 | Royan Institute | Method for derivation and long-term establishment of ground state pluripotent embryonic stem cells |
| BR112015030918A2 (en) * | 2013-06-11 | 2017-12-05 | Astellas Pharma Inc | method for producing renal progenitor cells, and drugs containing renal progenitor cells |
| NZ715302A (en) | 2013-06-14 | 2021-12-24 | Univ Queensland | Renal progenitor cells |
| CN103555660B (en) | 2013-09-09 | 2016-03-30 | 依科赛生物科技（太仓）有限公司 | A kind of embryonic stem cell serum free medium and application thereof |
-
2014
- 2014-06-13 NZ NZ715302A patent/NZ715302A/en unknown
- 2014-06-13 CN CN201480045180.3A patent/CN105473706B/en active Active
- 2014-06-13 SG SG11201510238TA patent/SG11201510238TA/en unknown
- 2014-06-13 CA CA2915097A patent/CA2915097C/en active Active
- 2014-06-13 JP JP2016518798A patent/JP2016527878A/en active Pending
- 2014-06-13 US US14/898,213 patent/US10900022B2/en active Active
- 2014-06-13 AU AU2014280843A patent/AU2014280843B2/en active Active
- 2014-06-13 EP EP14810526.5A patent/EP3011014A4/en active Pending
- 2014-06-13 KR KR1020167000925A patent/KR102375753B1/en active IP Right Grant
- 2014-06-13 RU RU2016100232A patent/RU2016100232A/en not_active Application Discontinuation
- 2014-06-13 BR BR112015031094A patent/BR112015031094A2/en not_active Application Discontinuation
- 2014-06-13 WO PCT/AU2014/000608 patent/WO2014197934A1/en active Application Filing
-
2016
- 2016-10-26 HK HK16112330.6A patent/HK1223976A1/en unknown
-
2019
- 2019-10-23 JP JP2019192404A patent/JP6937810B2/en active Active
-
2021
- 2021-01-22 US US17/155,631 patent/US20210371826A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3011014A4 (en) | 2017-02-08 |
| US10900022B2 (en) | 2021-01-26 |
| NZ715302A (en) | 2021-12-24 |
| US20160237409A1 (en) | 2016-08-18 |
| RU2016100232A (en) | 2017-07-17 |
| EP3011014A1 (en) | 2016-04-27 |
| CA2915097A1 (en) | 2014-12-18 |
| HK1223976A1 (en) | 2017-08-11 |
| AU2014280843A1 (en) | 2016-01-21 |
| US20210371826A1 (en) | 2021-12-02 |
| AU2014280843B2 (en) | 2017-04-20 |
| WO2014197934A1 (en) | 2014-12-18 |
| CA2915097C (en) | 2021-12-07 |
| KR20160030178A (en) | 2016-03-16 |
| BR112015031094A2 (en) | 2017-07-25 |
| KR102375753B1 (en) | 2022-03-18 |
| JP2016527878A (en) | 2016-09-15 |
| JP2020031648A (en) | 2020-03-05 |
| JP6937810B2 (en) | 2021-09-22 |
| CN105473706A (en) | 2016-04-06 |
| CN105473706B (en) | 2021-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1223976A1 (en) | Renal progenitor cells | |
| HK1223554A1 (en) | Cell | |
| HK1222338A1 (en) | Cell receptors | |
| HK1221724A1 (en) | Cell receptors | |
| EP2946517A4 (en) | Avoiding serving cell interruption | |
| EP3062378A4 (en) | Fuel cell | |
| EP2955778A4 (en) | Fuel cell | |
| EP2988346A4 (en) | Cell case | |
| EP2950377A4 (en) | Fuel cell | |
| GB201312332D0 (en) | Cell locations | |
| GB201310031D0 (en) | Cell | |
| GB201306326D0 (en) | Fuel cells | |
| GB201322430D0 (en) | T cell receptors | |
| GB201307880D0 (en) | Fuel cells | |
| GB201312803D0 (en) | Cell component | |
| GB201317614D0 (en) | Fuel cell | |
| GB201518180D0 (en) | Fuel cell | |
| GB201304514D0 (en) | Cell delivery | |
| AU2013904580A0 (en) | Renal progenitor cells | |
| AU2013902215A0 (en) | Renal progenitor cells | |
| GB201320573D0 (en) | T Cell | |
| GB201303132D0 (en) | Cell Line | |
| GB201317589D0 (en) | Cell | |
| GB201304302D0 (en) | Electrochemical cells |